1 / 3

Follicular Lymphoma Treatment Market

Follicular Lymphoma Treatment Market is expected to reach US$ XX Bn by 2026 from US$ XX Bn in 2017 at a CAGR of XX% Lymphoma is cancer of lymphatic system, which disturbs the cells of the immune system known as lymphocytes causesu2019 growth of the cells. Lymphocytes are the white blood cells which protect the body from the infection. It is of two types one is Non-Hodgkin and another is Hodgkin lymphoma. Follicular lymphoma is a type of Non-Hodgkin Lymphoma which affects the lymphocytes. Follicular lymphoma has symptoms like increase of the lymph nodes in the neck, shortness of breath, weight loss, night sweats. The rising prevalence of follicular lymphoma, family history of the disease, and increasing incidence of blood disorders worldwide are proving to be the key driving factors for Follicular Lymphoma Treatment Market. In addition, increasing research and development activities for the innovation of newer drugs and treatment methods and technological advancements in disease diagnosis would further fuel the follicular lymphoma market in the near future.

saritapatil
Download Presentation

Follicular Lymphoma Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Follicular Lymphoma Treatment Market – Industry Analysis & Forecast (2018-2026) by Treatment Type, End User andGeography. Follicular Lymphoma Treatment Marketis expected to reach US$ XX Bn by 2026 from US$ XX Bn in 2017 at a CAGR of XX% Lymphoma is cancer of lymphatic system, which disturbs the cells of the immune system known as lymphocytes causes’ growth of the cells. Lymphocytes are the white blood cells which protect the body from the infection. It is of two types one is Non- Hodgkin and another is Hodgkin lymphoma. Follicular lymphoma is a type of Non-Hodgkin Lymphoma which affects the lymphocytes. Follicular lymphoma has symptoms like increase of the lymph nodes in the neck, shortness of breath, weight loss, night sweats. The rising prevalence of follicular lymphoma, family history of the disease, and increasing incidence of blood disorders worldwide are proving to be the key driving factors forFollicular Lymphoma Treatment Market. In addition, increasing research and development activities for theinnovation of newer drugs and treatment methods and technological advancements in disease diagnosis would further fuel the follicular lymphoma market in the near future. However, the probable restraints like strict regulatory requirements for drug approval, high treatment cost, and adverse effects associated with different treatment methods should also be taken intoaccount. Follicular Lymphoma Treatment Market is segmented by Treatment Type, End User, and Geography. The key factors which drive the global follicular lymphoma treatment market in the forecast period are increasing the occurrence of follicular lymphoma, Genetic disease, and growth rate of blood disorders at a global level. However, firm regulatory requirements for drug approval, huge treatment cost, and adverse results related to different treatment methods may restrain the market. Furthermore, new therapies like monoclonal antibodies with government initiatives for cancer management are expected to boost the market. Radiation and chemotherapy are currently a reactive treatment for follicular lymphoma. However, radiation alone is used for the treatment of follicular lymphoma in maximum cases. In complex cases, chemotherapy alone is used for the treatment of follicular lymphoma. Moreover, Targeted Therapy is better than chemotherapy and Radiation, as they act directly by targeting tumour cells. Geographically North America follicular lymphoma treatment market is is expected to hold maximum market share during forecast period huge growth in the occurrence of thedisease in

  2. the region, mainly in the U.S. The market in Europe is also expected to expand significantly during the estimated period, because of firm health care infrastructure and rise in the occurrence of follicular lymphoma in the region. Some of the important players working at a global level contain Roche, Spectrum Pharmaceuticals, Johnson and Johnson, CTI Biopharma, Celgene, AbbVie Inc., Novartis, Amgen, Merck & Co. (MRK), Seattle Genetics, Pharmacyclics/ Bristol-Myers Squibb (BMY), and Bayer AG’S. In 2017, Bayer AG’s has launched the advanced drug, Aliqopa, also known as copanlisib, which is a kinase inhibitor which block certain enzymes responsible in cellgrowth. For More Information Visit https://www.maximizemarketresearch.com/market-report/follicular- lymphoma-treatment-market/12594/ Key Players in Follicular Lymphoma TreatmentMarket 1. AG 2. Seattle Genetics 3. Spectrum Pharmaceuticals 4. Celgene 5. Millennium/Johnson- Johnson 6. Merck 7. Pharmacyclics/Janssen Biotech 8. Kyowa Hakko Kirin 9. CTI Biopharm 10. Altor BioScience Corporation 11. Amgen Inc. 12. Astellas Pharma Inc. 13. Bayer AG 14. Boehringer Ingelheim GmbH 15. Roche 16. Spectrum Pharmaceuticals 17. Johnson andJohnson 18. CTI Biopharma 19. Celgene 20. AbbVie Inc 21. Novartis 22.Amgen Scope of the Follicular Lymphoma Treatment Market: Follicular Lymphoma Treatment Market, Treatment Type : ( Radiation, Targeted Therapy, and Chemotherapy) Follicular Lymphoma Treatment Market End User: ( Hospitals, Clinics, and Cancer Research Institutes) Follicular Lymphoma Treatment Market, byGeography: (North America, Europe, Asia Pacific, Middle East & Africa and Latin America) This Report Is Submitted By @Maximize Market Research Company Customization of thereport: Maximize Market Research provides free personalized of reports as per your demand.This report can be personalized to meet your requirements. Get in touch with us and oursales team will guarantee provide you to get a report thatsuits your necessities. About Maximize MarketResearch: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across theHealthcare,

  3. Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contactinfo: Name: LumawantGodage Organization: MAXIMIZE MARKET RESEARCH PVT.LTD. Email:sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk, Pune, Maharashtra 411051, India. Contact:+919607195908

More Related